US Stock MarketDetailed Quotes

ONCT Oncternal Therapeutics

Watchlist
  • 8.9000
  • +0.7210+8.82%
Trading May 13 11:57 ET
26.34MMarket Cap-721P/E (TTM)

Oncternal Therapeutics Key Stats

Oncternal Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 9, 2024

Revenue(YoY)

132.50K

-34.73%
EPS(YoY)

-2.88

+28.06%

Buy

May 13, 2024

Oncternal Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 218.330K--
--2024/Q2-- / 218.330K--
May 9, 20242024/Q1569.000K / 132.500K--
Mar 7, 20242023/Q4297.000K / 137.500K--
Nov 9, 20232023/Q3179.000K / 125.000K--
Aug 10, 20232023/Q2106.000K / 170.830K--
May 4, 20232023/Q1203.000K / 142.860K--
Mar 9, 20232022/Q4171.000K / 284.140K--
Nov 3, 20222022/Q3382.000K / 254.830K--
Aug 9, 20222022/Q2191.000K / 459.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 218.330K--
--2024/Q2-- / 218.330K--
May 9, 20242024/Q1569.000K / 132.500K--
Mar 7, 20242023/Q4297.000K / 137.500K--
Nov 9, 20232023/Q3179.000K / 125.000K--
Aug 10, 20232023/Q2106.000K / 170.830K--
May 4, 20232023/Q1203.000K / 142.860K--
Mar 9, 20232022/Q4171.000K / 284.140K--
Nov 3, 20222022/Q3382.000K / 254.830K--
Aug 9, 20222022/Q2191.000K / 459.000K--

Unlock Free Earnings Estimates

Oncternal Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 13, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg